347 related articles for article (PubMed ID: 15034041)
21. Unique and redundant roles of Smad3 in TGF-beta-mediated regulation of long bone development in organ culture.
Alvarez J; Serra R
Dev Dyn; 2004 Aug; 230(4):685-99. PubMed ID: 15254903
[TBL] [Abstract][Full Text] [Related]
22. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
[TBL] [Abstract][Full Text] [Related]
23. Smad3 null mice develop airspace enlargement and are resistant to TGF-beta-mediated pulmonary fibrosis.
Bonniaud P; Kolb M; Galt T; Robertson J; Robbins C; Stampfli M; Lavery C; Margetts PJ; Roberts AB; Gauldie J
J Immunol; 2004 Aug; 173(3):2099-108. PubMed ID: 15265946
[TBL] [Abstract][Full Text] [Related]
24. T cell activation leads to protein kinase C theta-dependent inhibition of TGF-beta signaling.
Giroux M; Delisle JS; O'Brien A; Hébert MJ; Perreault C
J Immunol; 2010 Aug; 185(3):1568-76. PubMed ID: 20592275
[TBL] [Abstract][Full Text] [Related]
25. CD28 co-stimulation regulates the effect of transforming growth factor-beta1 on the proliferation of naïve CD4+ T cells.
Sung JL; Lin JT; Gorham JD
Int Immunopharmacol; 2003 Feb; 3(2):233-45. PubMed ID: 12586604
[TBL] [Abstract][Full Text] [Related]
26. Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-beta (TGF-beta ) and the type II TGF-beta receptor.
Fanayan S; Firth SM; Butt AJ; Baxter RC
J Biol Chem; 2000 Dec; 275(50):39146-51. PubMed ID: 10993898
[TBL] [Abstract][Full Text] [Related]
27. Impaired TGF-beta responses in peripheral T cells of G alpha i2-/- mice.
Wu JY; Jin Y; Edwards RA; Zhang Y; Finegold MJ; Wu MX
J Immunol; 2005 May; 174(10):6122-8. PubMed ID: 15879107
[TBL] [Abstract][Full Text] [Related]
28. Smad7 is a TGF-beta-inducible attenuator of Smad2/3-mediated inhibition of embryonic lung morphogenesis.
Zhao J; Crowe DL; Castillo C; Wuenschell C; Chai Y; Warburton D
Mech Dev; 2000 May; 93(1-2):71-81. PubMed ID: 10781941
[TBL] [Abstract][Full Text] [Related]
29. Smad3: a key player in pathogenetic mechanisms dependent on TGF-beta.
Roberts AB; Russo A; Felici A; Flanders KC
Ann N Y Acad Sci; 2003 May; 995():1-10. PubMed ID: 12814934
[TBL] [Abstract][Full Text] [Related]
30. Distinct roles of Smad2-, Smad3-, and ERK-dependent pathways in transforming growth factor-beta1 regulation of pancreatic stellate cellular functions.
Ohnishi H; Miyata T; Yasuda H; Satoh Y; Hanatsuka K; Kita H; Ohashi A; Tamada K; Makita N; Iiri T; Ueda N; Mashima H; Sugano K
J Biol Chem; 2004 Mar; 279(10):8873-8. PubMed ID: 14688282
[TBL] [Abstract][Full Text] [Related]
31. IL-10 gene-deficient mice lack TGF-beta/Smad signaling and fail to inhibit proinflammatory gene expression in intestinal epithelial cells after the colonization with colitogenic Enterococcus faecalis.
Ruiz PA; Shkoda A; Kim SC; Sartor RB; Haller D
J Immunol; 2005 Mar; 174(5):2990-9. PubMed ID: 15728512
[TBL] [Abstract][Full Text] [Related]
32. SPARC inhibits epithelial cell proliferation in part through stimulation of the transforming growth factor-beta-signaling system.
Schiemann BJ; Neil JR; Schiemann WP
Mol Biol Cell; 2003 Oct; 14(10):3977-88. PubMed ID: 14517312
[TBL] [Abstract][Full Text] [Related]
33. IL-13 activates a mechanism of tissue fibrosis that is completely TGF-beta independent.
Kaviratne M; Hesse M; Leusink M; Cheever AW; Davies SJ; McKerrow JH; Wakefield LM; Letterio JJ; Wynn TA
J Immunol; 2004 Sep; 173(6):4020-9. PubMed ID: 15356151
[TBL] [Abstract][Full Text] [Related]
34. Transforming growth factor-beta1 inhibition of vascular smooth muscle cell activation is mediated via Smad3.
Feinberg MW; Watanabe M; Lebedeva MA; Depina AS; Hanai J; Mammoto T; Frederick JP; Wang XF; Sukhatme VP; Jain MK
J Biol Chem; 2004 Apr; 279(16):16388-93. PubMed ID: 14754879
[TBL] [Abstract][Full Text] [Related]
35. Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells.
Hayashida T; Decaestecker M; Schnaper HW
FASEB J; 2003 Aug; 17(11):1576-8. PubMed ID: 12824291
[TBL] [Abstract][Full Text] [Related]
36. Essential role for Smad3 in regulating MCP-1 expression and vascular inflammation.
Feinberg MW; Shimizu K; Lebedeva M; Haspel R; Takayama K; Chen Z; Frederick JP; Wang XF; Simon DI; Libby P; Mitchell RN; Jain MK
Circ Res; 2004 Mar; 94(5):601-8. PubMed ID: 14752027
[TBL] [Abstract][Full Text] [Related]
37. Alteration of transforming growth factor-beta1 response involves down-regulation of Smad3 signaling in myofibroblasts from skin fibrosis.
Reisdorf P; Lawrence DA; Sivan V; Klising E; Martin MT
Am J Pathol; 2001 Jul; 159(1):263-72. PubMed ID: 11438473
[TBL] [Abstract][Full Text] [Related]
38. c-Src and hydrogen peroxide mediate transforming growth factor-beta1-induced smooth muscle cell-gene expression in 10T1/2 cells.
Sato M; Kawai-Kowase K; Sato H; Oyama Y; Kanai H; Ohyama Y; Suga T; Maeno T; Aoki Y; Tamura J; Sakamoto H; Nagai R; Kurabayashi M
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):341-7. PubMed ID: 15591224
[TBL] [Abstract][Full Text] [Related]
39. Levels of phospho-Smad2/3 are sensors of the interplay between effects of TGF-beta and retinoic acid on monocytic and granulocytic differentiation of HL-60 cells.
Cao Z; Flanders KC; Bertolette D; Lyakh LA; Wurthner JU; Parks WT; Letterio JJ; Ruscetti FW; Roberts AB
Blood; 2003 Jan; 101(2):498-507. PubMed ID: 12393416
[TBL] [Abstract][Full Text] [Related]
40. TGF-beta down-regulates IL-6 signaling in intestinal epithelial cells: critical role of SMAD-2.
Walia B; Wang L; Merlin D; Sitaraman SV
FASEB J; 2003 Nov; 17(14):2130-2. PubMed ID: 14500551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
